Home » Pfizer Exec: Wyeth Added Value to Drug Pipeline
Pfizer Exec: Wyeth Added Value to Drug Pipeline
Martin Mackay, president of Pfizer Inc.’s PharmaTherapeutics research division, told a healthcare conference Tuesday in San Francisco that the company
received “great additions to the pipeline” when it acquired Wyeth Pharmaceuticals late last year.
The Day
The Day
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May